| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |